News
· 11hCEO of Novo Nordisk, maker of Wegovy, is stepping down
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company’s board of directors, citing “recent market challenges” and a steep decline in the company’s share price.
Novo Nordisk, the company that makes the weight loss drugs Ozempic and Wegovy, is abruptly ousting its chief executive, Lars Fruergaard Jørgensen, over concerns the firm is losing ground in the ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
Axios on MSN13h
Wegovy maker Novo Nordisk CEO to step downNovo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its ...
The usual dose of Novo Nordisk’s expensive weight-loss drug Wegovy can be cut in half without affecting the results, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback